Medical Technology

@xconomy.com 3 years ago

FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures

@xconomy.com 4 years ago

FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes

@xconomy.com 4 years ago

Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy

@xconomy.com 4 years ago

FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades

@xconomy.com 4 years ago

At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments

@xconomy.com 5 years ago

Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More

@xconomy.com 5 years ago

Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More

@xconomy.com 5 years ago

Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines

@xconomy.com 5 years ago

Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines